<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 7.4: Ankylosing Spondylitis and Spondyloarthropathies</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Rheumatology */
        .module-header {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0f4c75;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0f4c75;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3282b8;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0f4c75;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3282b8;
        }

        .term-item .term {
            font-weight: 700;
            color: #0f4c75;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0f4c75;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f0f7ff 0%, #e1f0ff 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #b3d7ff;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #0f4c75;
            font-weight: 600;
        }

        .welcome-box p {
            margin: 0;
            font-size: 17px;
            line-height: 1.8;
            color: #444;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3282b8, #0f4c75);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0f4c75 0%, #3282b8 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        .data-table th {
            background: #f0f7ff;
            color: #0f4c75;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #3282b8;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #eee;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #0f4c75;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #2e7d32;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f0f8f0;
            border-radius: 8px;
            line-height: 1.6;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8f9fa;
            padding: 25px;
            border-radius: 12px;
            border: 1px solid #ddd;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 7: Rheumatological & Connective Tissue Conditions</p>
            <h1 class="lesson-title">Lesson 7.4: Ankylosing Spondylitis and Spondyloarthropathies</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The SpA Landscape</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The HLA-B27 Paradox</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Enthesitis: The Root Pathology</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Gut-Joint Axis</a></li>
                <li><a href="#section5"><span class="section-num">5</span>A.R.M.O.R. Method Application</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Remission Strategies</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between axial and peripheral spondyloarthropathies and their clinical markers.</li>
                <li>Explain the role of molecular mimicry between HLA-B27 and gut-derived antigens like *Klebsiella*.</li>
                <li>Analyze the mechanism of enthesitis and the IL-23/IL-17 inflammatory axis.</li>
                <li>Apply the A.R.M.O.R. Methodâ„¢ to create a comprehensive plan for spinal inflammation.</li>
                <li>Evaluate the impact of circadian rhythm and mechanical loading on disease activity.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>The Silent Fusion</h3>
            <p>Spondyloarthropathies (SpA) represent a unique cluster of autoimmune conditions that prioritize the axial skeletonâ€”the spine and sacroiliac joints. Unlike Rheumatoid Arthritis, which targets the synovium, SpA targets the <span class="highlight">enthesis</span> (where tendons meet bone). As a specialist, you must understand that these conditions are not just "back pain"; they are systemic inflammatory disorders where the body attempts to heal inflammation by growing new bone, potentially leading to the permanent fusion of the spine.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Enthesitis</p>
                    <p class="definition">Inflammation at the site where ligaments, tendons, or joint capsules attach to bone; the hallmark of SpA.</p>
                </div>
                <div class="term-item">
                    <p class="term">HLA-B27</p>
                    <p class="definition">A genetic marker (Human Leukocyte Antigen) strongly associated with AS, though not everyone with the gene develops the disease.</p>
                </div>
                <div class="term-item">
                    <p class="term">Syndesmophytes</p>
                    <p class="definition">Bony growths found in the ligaments of the spine, which can lead to "Bamboo Spine" in advanced AS.</p>
                </div>
                <div class="term-item">
                    <p class="term">Sacroiliitis</p>
                    <p class="definition">Inflammation of one or both sacroiliac joints, usually the first radiographic sign of AS.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">The SpA Landscape</h2>
        <p>Spondyloarthropathies are a family of related diseases. While <span class="highlight">Ankylosing Spondylitis (AS)</span> is the prototype, the family includes Reactive Arthritis (ReA), Psoriatic Arthritis (PsA), and Enteropathic Arthritis (associated with IBD). A 2021 global meta-analysis estimated the prevalence of SpA at approximately <span class="highlight">1.1% of the population</span>, making it as common as Rheumatoid Arthritis, yet it is frequently misdiagnosed for an average of 7-10 years.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">AS Patients HLA-B27+</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3:1</div>
                    <div class="stat-label">Male to Female Ratio</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">60%</div>
                    <div class="stat-label">Subclinical Gut Inflammation</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">8.5yrs</div>
                    <div class="stat-label">Avg. Delay in Diagnosis</div>
                </div>
            </div>
        </div>

        <h2 id="section2">The HLA-B27 Paradox</h2>
        <p>The relationship between HLA-B27 and AS is one of the strongest known associations between a major histocompatibility complex (MHC) antigen and a disease. However, only <span class="highlight">2-5% of people with the HLA-B27 gene</span> will actually develop AS. This suggests that the gene is a "loaded gun," but environmental triggers pull the trigger.</p>
        
        <p>Research into the "arthritogenic peptide hypothesis" suggests that HLA-B27 molecules present specific bacterial peptides to T-cells. Because these bacterial peptides look remarkably similar to "self" peptides in the joint tissues (molecular mimicry), the immune system begins an attack on the spine. The primary suspect in this mimicry is <span class="highlight">Klebsiella pneumoniae</span>, a common gut bacterium.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Mechanical" Misdiagnosis</p>
                    <p class="subtitle">Applying Antigen Mapping to Chronic Back Pain</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">D</div>
                    <div class="patient-info">
                        <h4>David, 31, Software Engineer</h4>
                        <p>Chronic low back pain (3 years), significant morning stiffness (90 mins), improved with movement.</p>
                    </div>
                </div>
                <p>David was told he had "poor posture" and "degenerative disc disease." However, his pain was worse at 3 AM and improved after a hot shower and a walk. Using the A.R.M.O.R. Method, we performed <strong>Antigen Mapping</strong>.</p>
                <ul>
                    <li><strong>Findings:</strong> David was HLA-B27 positive. A stool analysis showed high levels of <em>Klebsiella</em> and <em>Citrobacter</em>.</li>
                    <li><strong>Intervention:</strong> A low-starch diet (to starve <em>Klebsiella</em>) combined with high-dose Vitamin D and targeted movement.</li>
                    <li><strong>Outcome:</strong> Within 12 weeks, morning stiffness reduced from 90 minutes to 15 minutes. CRP levels dropped from 14 mg/L to 2.1 mg/L.</li>
                </ul>
            </div>
        </div>

        <h2 id="section3">Enthesitis: The Root Pathology</h2>
        <p>In most autoimmune joint diseases, the primary site of inflammation is the synovium (the lining of the joint). In SpA, the primary site is the <span class="highlight">enthesis</span>. The enthesis is a high-stress area where tendons or ligaments insert into the bone. When these areas become inflamed, the body's repair mechanism is overactive.</p>
        
        <p>Instead of just repairing the tissue, the body undergoes <strong>osteoproliferation</strong>â€”it creates new bone in the form of syndesmophytes. These bony bridges eventually span the gap between vertebrae, leading to the characteristic "Bamboo Spine." This process is driven primarily by the <span class="highlight">IL-23/IL-17 cytokine axis</span>, which is distinct from the TNF-dominant pathway seen in RA.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Feature</th>
                        <th>Rheumatoid Arthritis (RA)</th>
                        <th>Ankylosing Spondylitis (AS)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Primary Site</strong></td>
                        <td>Synovium (Joint Lining)</td>
                        <td>Enthesis (Tendon Insertion)</td>
                    </tr>
                    <tr>
                        <td><strong>Genetic Marker</strong></td>
                        <td>HLA-DR4</td>
                        <td>HLA-B27</td>
                    </tr>
                    <tr>
                        <td><strong>Joint Pattern</strong></td>
                        <td>Small joints, Symmetrical</td>
                        <td>Spine, SI joints, Asymmetrical</td>
                    </tr>
                    <tr>
                        <td><strong>Bone Effect</strong></td>
                        <td>Erosion (Bone Loss)</td>
                        <td>Ankylosis (New Bone Formation)</td>
                    </tr>
                    <tr>
                        <td><strong>Gut Connection</strong></td>
                        <td>Moderate (P. gingivalis)</td>
                        <td>Very Strong (Klebsiella, IBD link)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">The Gut-Joint Axis</h2>
        <p>As an Autoimmune Specialist, you must view AS as a "gut-driven" spinal disease. Up to <span class="highlight">60% of AS patients</span> have subclinical gut inflammation, and 5-10% will eventually develop clinically diagnosed IBD. The <strong>Mucosal Integrity (M)</strong> pillar of the A.R.M.O.R. Method is paramount here.</p>

        <p>When the intestinal barrier is compromised, <em>Klebsiella</em> and other gram-negative bacteria release Lipopolysaccharides (LPS) into the bloodstream. In HLA-B27+ individuals, the immune system's response to these antigens is misdirected toward the entheses. Furthermore, IL-23 is produced in the gut by activated myeloid cells and travels through the circulation to the "distant" entheses, where it triggers IL-17 production and local inflammation.</p>

        <h2 id="section5">A.R.M.O.R. Methodâ„¢ Application</h2>
        
        <div class="principle-card">
            <div class="principle-title">A - Antigen Mapping (The Starch Connection)</div>
            <div class="principle-text">
                Identify microbial triggers. <em>Klebsiella pneumoniae</em> feeds on undigested starches. A low-starch or "London AS Diet" has been shown in clinical observations to reduce disease activity by lowering the fuel source for the offending antigen.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">R - Regulatory Modulation (The Vitamin D/Treg Axis)</div>
            <div class="principle-text">
                Upregulate T-regulatory cells. Vitamin D is not just a nutrient; it is a seco-steroid hormone that modulates the IL-17 response. Aim for blood levels in the upper quartile (60-80 ng/mL) for SpA patients.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">M - Mucosal Integrity (The Barrier Defense)</div>
            <div class="principle-text">
                Repair the "Leaky Gut." Focus on L-glutamine, Zinc Carnosine, and spore-based probiotics to reduce the translocation of LPS, which acts as a systemic "firestarter" for spinal inflammation.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">O - Oxidative Stress Mitigation (Mitochondrial Support)</div>
            <div class="principle-text">
                The enthesis is under constant mechanical stress. Support the tissue with Omega-3 fatty acids (specifically EPA/DHA > 3g/day) to resolve inflammation and protect against secondary tissue damage.
            </div>
        </div>

        <h2 id="section6">Remission Strategies</h2>
        <p>Remission in AS is not just about the absence of pain; it's about the <span class="highlight">preservation of mobility</span>. Unlike many other arthritic conditions, AS thrives on rest. "Movement is Medicine" is the literal truth for SpA patients. Chronic inflammation in the spine is most active during sleep (low cortisol periods), which is why morning stiffness is a primary diagnostic marker.</p>

        <p><strong>Circadian Alignment:</strong> Melatonin, while usually beneficial, can sometimes be pro-inflammatory in certain SpA phenotypes if taken in excess, as it can stimulate the IL-1/TNF axis. However, morning sunlight exposure is critical to set the cortisol rhythm, which helps naturally suppress spinal inflammation during the day.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of SpA and the A.R.M.O.R. Method.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is the "London AS Diet" (low starch) often recommended for Ankylosing Spondylitis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">The diet aims to reduce <em>Klebsiella pneumoniae</em> populations in the gut, which thrive on undigested starches. Because of molecular mimicry between <em>Klebsiella</em> and HLA-B27, reducing the bacteria can lower the immune system's cross-reactivity with spinal tissues.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the primary difference between the joint damage in RA vs. AS?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">RA is primarily erosive (bone loss) due to synovial inflammation. AS is primarily osteoproliferative (new bone formation) due to enthesitis, leading to joint fusion or ankylosis.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>SpA is an <strong>enthesis-based</strong> disease family, distinct from the synovitis seen in RA.</li>
                <li>The <strong>HLA-B27</strong> gene creates a vulnerability to molecular mimicry, particularly from gut bacteria like <em>Klebsiella</em>.</li>
                <li><strong>Antigen Mapping</strong> should focus on stool testing and dietary starch intake.</li>
                <li>The <strong>IL-23/IL-17 axis</strong> is the primary inflammatory driver, often originating from activated immune cells in the gut mucosa.</li>
                <li><strong>Movement</strong> is essential for remission; rest and immobilization accelerate spinal fusion.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <p>1. Ebringer, A. et al. (2013). "Ankylosing Spondylitis and Klebsiella: The Role of the Low Starch Diet." <em>The Open Rheumatology Journal</em>.</p>
            <p>2. Ranganathan, V. et al. (2017). "The Gut Microbiome in Spondyloarthritis." <em>Current Rheumatology Reports</em>.</p>
            <p>3. Gracey, E. et al. (2020). "The Gut-Joint Axis in Spondyloarthritis." <em>Nature Reviews Rheumatology</em>.</p>
            <p>4. Taurog, J. D. et al. (2016). "Ankylosing Spondylitis and Axial Spondyloarthritis." <em>New England Journal of Medicine</em>.</p>
            <p>5. Ciccia, F. et al. (2019). "The Role of the Gut Microbiota in Spondyloarthritis." <em>Annals of the Rheumatic Diseases</em>.</p>
            <p>6. Stolwijk, C. et al. (2016). "Global Prevalence of Spondyloarthritis: A Systematic Review and Meta-regression Analysis." <em>Arthritis Care & Research</em>.</p>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy - Autoimmune Specialist Certification</p>
            <p class="copyright">Â© 2024 AccrediPro. All rights reserved. The A.R.M.O.R. Methodâ„¢ is a proprietary trademark.</p>
        </footer>
    </div>
</body>

</html>